Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Clinical trial NCT04229303 · COMPLETED

Trial details

NCT number: NCT04229303
Sponsor: Zambon SpA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Bronchopulmonary Aspergillosis

Start date: 2020-02-11
Primary completion: 2020-08-31
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.